Singh N, Ramnarine V, Song J, Pandey R, Padi S, Nouri M, et al. The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nat Commun. 2021;12:7349 pubmed publisher

Klein F, Granier C, Zhao Y, Pan Q, Tong Z, Gschwend J, et al. Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer. J Pers Med. 2021;11: pubmed publisher

He T, Wildey G, McColl K, Savadelis A, Spainhower K, McColl C, et al. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer. Mol Oncol. 2021;15:195-209 pubmed publisher

Wu Q, Ba Alawi W, Deblois G, Cruickshank J, Duan S, Lima Fernandes E, et al. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. Nat Commun. 2020;11:4205 pubmed publisher

Kim K, Godarova A, Seedle K, Kim M, Ince T, Wells S, et al. Rb suppresses collective invasion, circulation and metastasis of breast cancer cells in CD44-dependent manner. PLoS ONE. 2013;8:e80590 pubmed publisher

Michaud K, Solomon D, Oermann E, Kim J, Zhong W, Prados M, et al. Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts. Cancer Res. 2010;70:3228-38 pubmed publisher